N-(1-Hydroxy-1-phenylpropan-2-YL)dodecanamide | 919770-82-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(1-Hydroxy-1-phenylpropan-2-YL)dodecanamide
• CAS: 919770-82-4
• 化学式: C₂₁H₃₅NO₂
• 分子量: 333.5
• InChiKey: FFDGVCBKSOZLSV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6
• 重原子数：
  24
• 可旋转键数：
  13
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• USE OF MONO AND BICARBOXYLIC ACID AMIDES FOR THE MANUFACTURE OF A MEDICAMENT ACTIVE AT THE PERIPHERAL CANNABINOID RECEPTOR
  申请人：LIFEGROUP S.p.A.

  公开号：EP0799033A1

  公开（公告）日：1997-10-08
• INHIBITORS OF ANOREXIC LIPID HYDROLYSIS FOR THE TREATMENT OF EATING DISORDERS
  申请人：Hansen Harald S.

  公开号：US20090054526A1

  公开（公告）日：2009-02-26

  Compounds, pharmaceuticals, cosmetic or dietary supplements for the treatment of overweight, obesity and/or type II diabetes in a mammal (e.g. human) comprising a compound with formula I or formula II for example ceramidase-inhibitor, such as (1S,2R)-D-ery-thro-2-(N-myristoylamino)-1-phenyl-1-propanol, alone or in combination with an anorexic lipid (or other appetite-inhibiting acylamides or oleoyl-estrone), and methods of treatment comprising administration of said compounds, pharmaceuticals, cosmetic or a dietary supplements. The compounds, pharmaceuticals, cosmetic or dietary supplements and methods of the invention may further be used in modifying the feeding behaviour, suppression of hunger, enhancement of satiety, reduction of energy intake, reduction of fat tissue mass/lean mass ratio in a mammal (e.g. human).
• US5990170A
  申请人：——

  公开号：US5990170A

  公开（公告）日：1999-11-23
• [EN] USE OF MONO AND BICARBOXYLIC ACID AMIDES FOR THE MANUFACTURE OF A MEDICAMENT ACTIVE AT THE PERIPHERAL CANNABINOID RECEPTOR<br/>[FR] UTILISATION D'AMIDES D'ACIDES MONO ET BICARBOXYLIQUE DANS LA FABRICATION D'UN MEDICAMENT ACTIF SUR LE RECEPTEUR PERIPHERIQUE DES CANNABINOIDES
  申请人：LIFEGROUP S.P.A.

  公开号：WO1996018391A2

  公开（公告）日：1996-06-20

  (EN) The following description concerns the therapeutic use of amidic derivatives of mono and bicarboxylic acids with aminoalcohols or aminoethers in the manufacture of a medicament for the treatment of diseases connected with the modulation of the cannabinoid peripheral receptor, said amidic derivatives being selectively active on said receptor.(FR) La description suivante concerne l'utilisation thérapeutique de dérivés amides d'acides mono et bicarboxylique avec des amino-alcools ou des amino-éthers, dans la fabrication d'un médicament destiné au traitement de maladies associées à la modulation du récepteur périphérique des cannabinoïdes, ces dérivés amides étant actifs de façon sélective sur ledit récepteur.